• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者肠道紧密连接表达改变:肠道高通透性的发病机制。

Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability.

机构信息

Department of Internal Medicine, University Hospital of Patras, Patras, Greece.

出版信息

Eur J Clin Invest. 2012 Apr;42(4):439-46. doi: 10.1111/j.1365-2362.2011.02609.x. Epub 2011 Oct 24.

DOI:10.1111/j.1365-2362.2011.02609.x
PMID:22023490
Abstract

BACKGROUND

Increased intestinal permeability in cirrhosis exerts a pivotal role in the pathogenesis of spontaneous bacterial peritonitis and other complications of cirrhosis through promotion of systemic endotoxemia. This study was designed to investigate whether the expression of tight junction (TJ) proteins, which regulate gut paracellular permeability, is altered in the intestinal mucosa of patients with liver cirrhosis and study its potential association with the stage of liver disease and the development of systemic endotoxemia.

DESIGN

Twenty-four patients with cirrhosis at a decompensated (n = 12, group A) or compensated condition (n = 12, group B) and 12 healthy controls (group C) were subjected to duodenal biopsy. The expression of the TJ proteins occludin and claudin-1 in the intestinal epithelium was evaluated by immunohistochemistry. Plasma endotoxin concentrations were also determined.

RESULTS

Patients with cirrhosis presented significantly higher serum endotoxin concentrations as compared to healthy controls (P < 0·001), whilst endotoxemia was higher in decompensated disease (P < 0·05 vs. compensated cirrhosis). Patients with decompensated and compensated cirrhosis presented significantly reduced expression of occludin and claudin-1 as compared to controls (P < 0·01, respectively). These alterations were significantly more pronounced in decompensated patients as compared to compensated (P < 0·05). Regarding occludin, in patients with cirrhosis, a specific pattern of expression in the intestinal epithelium was observed, with a gradually increasing loss of expression from crypt to tip of the villi. Occludin and claudin-1 expression were inversely correlated with Child-Pugh score (P < 0·001), the grade of oesophageal varices (P < 0·01) and endotoxin concentrations (P < 0·001).

CONCLUSIONS

This study demonstrates for the first time that human liver cirrhosis induces significant alterations in enterocytes' TJs. These changes might represent an important cellular mechanism for intestinal barrier dysfunction and hyperpermeability in patients with liver cirrhosis.

摘要

背景

肝硬化患者的肠道通透性增加,通过促进全身内毒素血症,在自发性细菌性腹膜炎和其他肝硬化并发症的发病机制中发挥关键作用。本研究旨在探讨肝硬化患者肠道黏膜中紧密连接(TJ)蛋白的表达是否发生改变,以及其与肝病分期和全身内毒素血症的发展之间的潜在关联。

设计

对 24 例失代偿期(n=12,A 组)和代偿期(n=12,B 组)肝硬化患者和 12 例健康对照者(C 组)进行十二指肠活检。通过免疫组织化学方法评估肠道上皮 TJ 蛋白 occludin 和 claudin-1 的表达。还测定了血浆内毒素浓度。

结果

与健康对照组相比,肝硬化患者的血清内毒素浓度显著升高(P<0·001),而失代偿期疾病患者的内毒素血症更高(P<0·05 与代偿期肝硬化相比)。与对照组相比,失代偿期和代偿期肝硬化患者的 occludin 和 claudin-1 表达均显著降低(分别为 P<0·01)。与代偿期患者相比,失代偿期患者的这些改变更为明显(P<0·05)。关于 occludin,在肝硬化患者中,观察到肠道上皮细胞中存在特定的表达模式,从隐窝到绒毛顶端,表达逐渐减少。occludin 和 claudin-1 的表达与 Child-Pugh 评分(P<0·001)、食管静脉曲张程度(P<0·01)和内毒素浓度(P<0·001)呈负相关。

结论

本研究首次证明,人类肝硬化会引起肠细胞 TJ 显著改变。这些变化可能代表肝硬化患者肠道屏障功能障碍和高通透性的重要细胞机制。

相似文献

1
Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability.肝硬化患者肠道紧密连接表达改变:肠道高通透性的发病机制。
Eur J Clin Invest. 2012 Apr;42(4):439-46. doi: 10.1111/j.1365-2362.2011.02609.x. Epub 2011 Oct 24.
2
Evidence for tight junction protein disruption in intestinal mucosa of malignant obstructive jaundice patients.恶性梗阻性黄疸患者肠黏膜紧密连接蛋白破坏的证据。
Scand J Gastroenterol. 2010;45(2):191-9. doi: 10.3109/00365520903406701.
3
Intestinal mucosal proliferation, apoptosis and oxidative stress in patients with liver cirrhosis.肝硬化患者的肠黏膜增殖、凋亡和氧化应激。
Ann Hepatol. 2013 Mar-Apr;12(2):301-7.
4
Large intestine permeability is increased in patients with compensated liver cirrhosis.代偿期肝硬化患者的大肠通透性增加。
Am J Physiol Gastrointest Liver Physiol. 2014 Jan;306(2):G147-53. doi: 10.1152/ajpgi.00330.2013. Epub 2013 Nov 21.
5
The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype.在不同亚型的肠易激综合征患者中,紧密连接蛋白的表达和细胞分布发生改变。
Am J Gastroenterol. 2011 Dec;106(12):2165-73. doi: 10.1038/ajg.2011.257. Epub 2011 Oct 18.
6
Increased intestinal permeability in malnourished patients with liver cirrhosis.肝硬化营养不良患者的肠道通透性增加。
Eur J Clin Nutr. 2012 Oct;66(10):1116-9. doi: 10.1038/ejcn.2012.104. Epub 2012 Aug 8.
7
The role of the gut barrier function in the pathophysiology of viral liver cirrhosis.肠道屏障功能在病毒性肝硬化病理生理学中的作用。
Hepatogastroenterology. 2011 Jul-Aug;58(109):1244-7. doi: 10.5754/hge10338.
8
Altered Expression of Intestinal Tight Junctions in Patients with Chronic Kidney Disease: A Pathogenetic Mechanism of Intestinal Hyperpermeability.慢性肾脏病患者肠道紧密连接的表达改变:肠道通透性增加的发病机制
Biomedicines. 2024 Feb 5;12(2):368. doi: 10.3390/biomedicines12020368.
9
IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats.胰岛素样生长因子-1通过调节肠道紧密连接降低门静脉内毒素,并在减轻肝硬化大鼠门静脉高压中发挥作用。
BMC Gastroenterol. 2015 Jul 8;15:77. doi: 10.1186/s12876-015-0311-5.
10
Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls.与代偿期肝硬化患者和健康对照组相比,失代偿期肝硬化患者的肠道转运时间较慢。
J Clin Gastroenterol. 2013 Nov-Dec;47(10):888-93. doi: 10.1097/MCG.0b013e31829006bb.

引用本文的文献

1
The role of bacterial outer membrane vesicles in inflammatory response of acute-on-chronic liver failure.细菌外膜囊泡在慢加急性肝衰竭炎症反应中的作用
Front Microbiol. 2025 Jul 4;16:1608137. doi: 10.3389/fmicb.2025.1608137. eCollection 2025.
2
Role of Intestinal Microbiome in Potentiating Inflammation and Predicting Outcomes in Alcohol-Associated Cirrhosis.肠道微生物群在增强酒精性肝硬化炎症及预测预后中的作用
Gastroenterol Clin North Am. 2025 Jun;54(2):453-467. doi: 10.1016/j.gtc.2024.12.001. Epub 2025 Jan 18.
3
Surrogate Markers of Intestinal Permeability, Bacterial Translocation and Gut-Vascular Barrier Damage Across Stages of Cirrhosis.
肝硬化各阶段肠道通透性、细菌移位和肠-血管屏障损伤的替代标志物
Liver Int. 2025 Jun;45(6):e70119. doi: 10.1111/liv.70119.
4
Machine learning algorithms reveal gut microbiota signatures associated with chronic hepatitis B-related hepatic fibrosis.机器学习算法揭示了与慢性乙型肝炎相关肝纤维化相关的肠道微生物群特征。
World J Gastroenterol. 2025 Apr 28;31(16):105985. doi: 10.3748/wjg.v31.i16.105985.
5
New insights into the intestinal barrier through "gut-organ" axes and a glimpse of the microgravity's effects on intestinal barrier.通过“肠-器官”轴对肠道屏障的新见解以及对微重力对肠道屏障影响的一瞥。
Front Physiol. 2024 Oct 10;15:1465649. doi: 10.3389/fphys.2024.1465649. eCollection 2024.
6
The epithelial barrier theory and its associated diseases.上皮屏障理论及其相关疾病。
Allergy. 2024 Dec;79(12):3192-3237. doi: 10.1111/all.16318. Epub 2024 Oct 7.
7
Infections in decompensated cirrhosis: Pathophysiology, management, and research agenda.失代偿期肝硬化感染:病理生理学、治疗和研究议程。
Hepatol Commun. 2024 Oct 3;8(10). doi: 10.1097/HC9.0000000000000539. eCollection 2024 Oct 1.
8
Potential mechanisms of traditional Chinese medicine in the treatment of liver cirrhosis: a focus on gut microbiota.中医治疗肝硬化的潜在机制:聚焦肠道微生物群
Front Microbiol. 2024 Aug 21;15:1407991. doi: 10.3389/fmicb.2024.1407991. eCollection 2024.
9
Therapeutic effect of fecal microbiota transplantation on rats with liver cirrhosis and its influence on gut microbiota.粪便微生物群移植对肝硬化大鼠的治疗作用及其对肠道微生物群的影响。
Iran J Basic Med Sci. 2024;27(9):1148-1154. doi: 10.22038/IJBMS.2024.74280.16142.
10
Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis.可溶性髓系细胞触发受体-1作为细菌移位的生物标志物及肝硬化患者益生菌使用指征
World J Hepatol. 2024 May 27;16(5):822-831. doi: 10.4254/wjh.v16.i5.822.